riverhead semaglutide & tirzepatide vs in Ponte Vedra: Which Is More Effective? — BlueWater Wellness MedSpa First head-to-head study in people
Description
Regional Analysis North America led the GLP-1 market with a 57% share in 2025, due to the high prevalence of obesity and type 2 diabetes, alongside a healthcare system where there is early access to new medications via the FDAs fast-track pathway and extensive insurance that makes such expensive medications accessible to millions of patients
For those with a lower appetite who still need balanced nutrition, protein meal replacements are another helpful option
Wegovy contains the GLP-1 analogue semaglutide
Ritter, E
